On February 13, 2024, Allarity Therapeutics, Inc. closed the transaction.The company raised a senior convertible promissory note for the gross proceeds of $400,000 in its second and final tranche.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.201 USD | -3.37% |
|
-54.45% | -98.18% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-98.18% | 3.54M | |
+16.49% | 122B | |
+21.73% | 115B | |
+22.21% | 26.64B | |
-21.81% | 19.91B | |
-16.89% | 16.32B | |
-18.81% | 15.49B | |
-44.74% | 15.52B | |
+62.72% | 14.83B | |
+3.09% | 13.67B |
- Stock Market
- Equities
- ALLR Stock
- News Allarity Therapeutics, Inc.
- Allarity Therapeutics, Inc. announced that it has received $0.8 million in funding from 3i, LP